Qianqian Liu; Qi Bi; Siyu Liu; Yuexin Xiu; Fuzhen Wang; Zundong Yin; Xiaoxue Liu; Qianqian Liu; Qi Bi; Siyu Liu; Yuexin Xiu; Fuzhen Wang; Zundong Yin; Xiaoxue Liu

doi:10.46234/ccdcw2025.094

[1]

Minta AA, Ferrari M, Antoni S, Lambert B, Sayi TS, Hsu CH, et al. Progress toward measles elimination—worldwide, 2000−2023. MMWR Morb Mortal Wkly Rep 2024;73(45):1036 − 42. https://doi.org/10.15585/mmwr.mm7345a4.

[2]

WHO. Immunization data. https://immunizationdata.who.int/global?topic=&location=. [2025-3-7].

[3]

Crowcroft NS, Minta AA, Bolotin S, Cernuschi T, Ariyarajah A, Antoni S, et al. The problem with delaying measles elimination. Vaccines (Basel) 2024;12(7):813. https://doi.org/10.3390/vaccines12070813.

[4]

Sato S, Ono S, Sasabuchi Y, Uemura K, Yasunaga H. Changes in the mumps vaccine coverage and incidence of mumps before and after the public subsidization program: a descriptive study using a population-based database in Japan. Am J Infect Control 2025;53(1):82 − 6. https://doi.org/10.1016/j.ajic.2024.09.011.

[5]

Kaur G, Danovaro-Holliday MC, Mwinnyaa G, Gacic-Dobo M, Francis L, Grevendonk J, et al. Routine vaccination coverage—worldwide, 2022. MMWR Morb Mortal Wkly Rep 2023;72(43):1155 − 61. https://doi.org/10.15585/mmwr.mm7243a1.

[6]

Ou AC, Zimmerman LA, Alexander Jr JP, Crowcroft NS, O’Connor PM, Knapp JK. Progress toward rubella and congenital rubella syndrome elimination—worldwide, 2012−2022. MMWR Morb Mortal Wkly Rep 2024;73(8):162 − 7. https://doi.org/10.15585/mmwr.mm7308a2.

[7]

Xu X, Liu SY, Tang L, Liu QQ, Yin ZD, Wang FZ. Progress toward congenital rubella syndrome surveillance and surveillance methods: a literature review. Chin J Vaccines Immunization 2023;29(6):719 − 26. https://doi.org/10.19914/j.CJVI.2023124.

[8]

Yang H, Ma C, Ding YX, Li Z, Liu XD, Wang FZ, et al. Comparison of mumps incidence in areas of China with different immunization strategies, 2012−2019. Chin J Vaccines Immunization 2021;27(3):242 − 5,296. https://doi.org/10.19914/j.CJVI.2021042.

[9]

Masresha BG, Hatcher C, Lebo E, Tanifum P, Bwaka AM, Minta AA, et al. Progress toward measles elimination—African region, 2017−2021. MMWR Morb Mortal Wkly Rep 2023;72(36):985 − 91. https://doi.org/10.15585/mmwr.mm7236a3.

[10]

Cutts FT, Ferrari MJ, Krause LK, Tatem AJ, Mosser JF. Vaccination strategies for measles control and elimination: time to strengthen local initiatives. BMC Med 2021;19(1):2. https://doi.org/10.1186/s12916-020-01843-z.

[11]

Liu SY, Liu QQ, Li JH, Tang L, Wang XQ, Yang H, et al. Epidemiology of measles in China, 2021−2022. Chin J Vaccines Immunization 2024;30(1):29 − 33. https://doi.org/10.19914/j.CJVI.2024006.

[12]

Ye JK, Cao L, Yu WZ, Song YF, Yin ZD. Reported routine immunization coverage with National Immunization Program vaccines in China, 2020−2021. Chin J Vaccines Immunization 2022;28(5):576 − 80. https://doi.org/10.19914/j.CJVI.2022110.

[13]

Durrheim DN, Xu AQ, Baker MG, Hsu LY, Takashima Y. China has the momentum to eliminate measles. Lancet Reg Health West Pac 2023;30:100669. https://doi.org/10.1016/j.lanwpc.2022.100669.